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Abstract
The importance of microRNAs in development is now widely accepted. However, identifying the specific targets of
individual microRNAs and understanding their biological significance remains a major challenge. We have used the
zebrafish model system to evaluate the expression and function of microRNAs potentially involved in muscle development
and study their interaction with predicted target genes. We altered expression of the miR-30 microRNA family and
generated phenotypes that mimicked misregulation of the Hedgehog pathway. Inhibition of the miR-30 family increases
activity of the pathway, resulting in elevated ptc1 expression and increased numbers of superficial slow-muscle fibres. We
show that the transmembrane receptor smoothened is a target of this microRNA family. Our results indicate that fine
coordination of smoothened activity by the miR-30 family allows the correct specification and differentiation of distinct
muscle cell types during zebrafish embryonic development.
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Introduction
Gene regulation during vertebrate embryonic development is
complex and requires precise regulation and control. MicroRNAs
are small ribonucleic acids, 19–25 nucleotides in length, which
fulfil key roles in multiple cellular processes including cell fate
specification, cell signalling and organogenesis by acting at the
post-transcriptional level to down-regulate the translation of target
mRNAs. Nucleotides 2–8 of the microRNA represent the seed
sequence and are the most crucial for target binding [1].
Complementarity between this region and an mRNA transcript
target is required, but secondary structure and accessibility of the
mRNA site are also key factors in target recognition [2,3]. This
makes microRNA target identification complex, and despite
extensive investigation little is known about the specific targets of
many microRNAs.
The Hh signalling pathway is one of the most extensively
studied developmental pathways and is a key regulator of early
embryonic development conserved from drosophila to humans [4–
7]. Hedgehog (Hh) is a morphogen which acts to specify cell fate
by establishing a graded distribution in the developing embryo.
The timing and concentration of Hh exposure is critical for correct
tissue specification [8,9] and the establishment of an Hh
concentration gradient across surrounding cells results in distinct
differentiation responses. Multiple developmental systems are
affected following disruption of the Hedgehog pathway, including
the brain [10] muscle [11–14], gastrointestinal system [15] and the
limbs [16–18] The pathway has also been shown to be critical in
the development of numerous cancers, in particular basal cell
carcinoma [19].
A number of studies have looked at the potential for microRNA
regulation of the Hedgehog (Hh) pathway due to its importance in
the induction and patterning of the vertebrate embryo [20] and its
strong association with the development of many cancers.
MicroRNA dysregulation has been associated with many tumour
types and specifically miR-212 has been linked to lung cancer
progression via its negative regulatory activity against the Ptc1
receptor [21]. In addition, microarray analysis has determined a
subset of microRNAs that demonstrate significant changes in
expression as a result of Hh pathway activation levels [22,23]. The
Hh pathway regulator, Suppressor of Fused (SuFu), is directly
targeted by miR-214 and this interaction affects muscle fibre
specification in the developing zebrafish embryo by regulating the
transcription factor Gli1 and maintaining the required levels of Hh
activity in the muscle progenitor cells [20]. A drosophila
microRNA cluster, miR-12/miR-283 and miR-304 [24], in
addition to miR-960 have been shown to negatively regulate key
members of the Hh pathway Smoothened, Costal-2 and Fused
[25]. Together this data demonstrates the importance of
microRNA regulation in the Hh signalling pathway.
A strong link has been established previously between Hh
signalling and the distinct muscle cell types within the developing
embryo. Hh signalling is required for the establishment of
superficial slow muscle fibres, muscle pioneer cells and a subset
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of fast muscle fibres; medial fast fibres [26,27]. Early in
development slow muscle progenitor cells are located in the most
medial position receiving early Hedgehog signal from the
notochord [26]. Lateral cells positioned further from the
notochord receive lower levels of Hh signal and differentiate to
fast muscle fibres independent of Hh activity. Once specified, slow-
muscle cells migrate through the fast muscle precursors to become
the most superficial layer of muscle. This movement induces the
fast muscle precursors to undergo morphogenesis [13,27,28]. Here
we report a biological role for the miR-30 family in zebrafish
embryonic muscle development by regulation of Hedgehog
pathway activity. We observe phenotypic similarities between
miR-30 knockdown and Hh misexpression and show that
Smoothened protein levels are directly affected in vivo. Our results
suggest that the miR-30 microRNA family is a critical regulator of
muscle cell specification and differentiation.
Results
The miR-30 Family is Required for Early Muscle
Development
The miR-30 family has been studied extensively and has been
used to identify the precise mechanisms of Drosha activity [29], as
well as the sequence requirements for miRNA biogenesis and
function [30]. The miR-30 family is known to regulate several
biological processes, including pancreatic islet cell development
[31], mitochondrial fission [32], adipogenesis [33] and osteoblast
differentiation [34]. Duisters et al. (2009) were the first to report a
target, connective tissue growth factor, for miR-30 [35]. Since
then, several potential targets of miR-30 regulation have been
identified, many of which are implicated in the development of
cancer [36–38].
The family is made up of 5 members, termed miR-30a-30e,
between which, the sequence homology is extremely high with
100% conservation in the seed sequence (Fig. 1). The miR-30
family members are encoded from 3 different genomic locations
and form 3 microRNA clusters. In order to understand the role of
the miR-30 family we conducted a series of experiments using the
zebrafish model system. In situ hybridisation with Locked Nucleic
Acid (LNA) probes showed that the miR-30 family was detected as
early as 8 hpf, unusual for miRNAs in zebrafish [39]. By 26 hpf
the expression pattern of miR-30a-30e is overlapping and
ubiquitous with noticeable expression in the cerebellum, retina
and somites, while miR-30e shows additional expression in the
linear heart tube (Fig. S1A). MicroRNA clusters generally
demonstrate matching expression profiles, although additional
post-transcriptional regulation mechanisms and differing biologi-
cal contexts are predicted to cause variation in the expression of
microRNA genes generated from the same transcripts [40,41].
Expression analysis of the miR-30 family was carried out in
parallel with control experiments using a sense LNA probe for
miR-159, as recommended by the manufacturer, which had no
detectable expression at the same developmental time points (Fig.
S1B).
The miR-30 microRNAs show strong sequence similarity and
overlapping expression patterns, which may result in functional
redundancy. To assess the role of the entire miR-30 family, a
multi-blocking morpholino was designed to knock-down all 5
family members simultaneously in one experiment (Fig. 2). The
morpholino was designed to target the pre-mRNA sequence and
prevent processing from the primary transcript. The miR-30
family morpholino is 35 bp in length. This spans the entire mature
microRNA sequences and the drosha and dicer cleavage sites. The
increased length reduces the percentage of mismatches between
family members therefore increasing the probability of complete
family knockdown. Morpholino activity was verified using a GFP
reporter assay, as described in [20]. A GFP reporter construct was
made with the GFP open reading frame followed by perfect target
sites for the miR-30 microRNA. This was injected into embryos
singly, with the miR-30 RNA and with both the miR-30 RNA and
the miR-30 morpholino. This experiment demonstrated the
effectiveness of the miR-30 morpholino, as shown by a rescue in
the levels of GFP protein. GFP protein was quantified by Western
blot and demonstrated 72% inhibition of miR-30 activity by the
morpholino (Fig. S2).
MicroRNA-30 family knockdown produced a severe muscle
phenotype, (Fig. 2A and 2B) indicating a potentially crucial role in
early embryonic development. Previous studies have described
minor phenotypic changes as a result of microRNA misexpression,
which coincides with the ability of most proteins to tolerate
alterations in expression levels [42]. Injection of the miR-30
morpholino yielded embryos with broader, rounded U-shaped
somites and alteration of the tail size and structure (Fig. 2B).
Embryos displayed a reduction in length of the yolk cell extension,
which together with the somite defects resulted in an overall
ventral curvature of the embryonic axis.
As a negative control for the knockdown studies an unrelated
microRNA was selected to ensure the phenotypes observed were
specific to knockdown of the miR-30 family and was not a generic
consequence of morpholino introduction. MicroRNA-140 was
chosen as it has no reported similarity to any members of the miR-
30 family and previous expression analysis in zebrafish has shown
that miR-140 is expressed in the palatal skeleton and head
cartilage [42,43] No phenotype was observed in these embryos
(Fig. S1C).
miR-30 Misregulation Affects Hh Pathway Activity
Zebrafish mutants for well characterised molecular pathways
have been reported and multiple studies point to the develop-
mental consequences of perturbing Hedgehog (Hh) signalling,
which shows acute dosage sensitivity [44–46]. We noticed that the
phenotype we generated by alterations in the level of the miR-30
family mimics misregulation of the Hh pathway, displaying
downwards curvature of the embryos and characteristic U-shaped
somites associated with Hh pathway misregulation (Fig. 2B)
[14,47]. To determine whether the miR-30 knock down pheno-
type was due to a mis-regulation of Hh signalling we analysed ptc1
expression as a read out of Hh activity (Fig. 2E–H) [48,49]. Ptc1
encodes an Hh ligand receptor, transcription of which is activated
by Hh signalling [48]. In situ hybridisation of 24 hpf embryos
injected with the miR-30 morpholino exhibited increased ptc1
Figure 1. The miR-30 microRNA family shows high sequence
similarity and overlapping expression patterns throughout
embryonic development. The miR-30 family shows extremely high
sequence similarity and an identical seed sequence, as highlighted by
the red box.
doi:10.1371/journal.pone.0065170.g001
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expression (Fig. 2F) suggesting upregulation of the pathway. As a
positive control for Hh pathway activation dnPKA mRNA
(dominant negative Protein Kinase A) was injected into zebrafish
embryos (Fig. 2C,G,K). Protein kinase A is a negative regulator of
Hedgehog signaling and injection of dnPKA leads to over-
activation of the pathway [47]. There is significant similarity
between the embryos treated with dnPKA and the miR-30
knockdown embryos, with primary defects in the early patterning
and establishment of the somites resulting in U shaped somites and
overall curvature of the embryo. To further verify that miR-30
levels are linked to Hh pathway activity a miR-30 RNA sequence
duplex was overexpressed in zebrafish embryos (Fig. 2D,H,L) and
showed reduced ptc1 expression (Fig. 2H), suggesting that the
microRNA family is involved in regulating Hh pathway activity.
These experiments indicate that the miR-30 family has a negative
regulatory role on the level of Hedgehog signaling during zebrafish
embryonic development.
miR-30 is Required for Correct Specification of the
Distinct Muscle Cell Types
Hh signalling is critical to correct muscle specification and
studies by others have shown that over-activation of the Hh
pathway in the presomitic mesoderm causes a complete switch of
presomitic cells to superficial slow-muscle fibre fate at the expense
of fast twitch fibres [13,14,50]. To evaluate the role of the miR-30
family in muscle development we investigated the effect of miR-30
up- and downregulation on muscle fibre distribution by immuno-
histochemistry. Antibodies against both slow and fast twitch
muscle fibres were used to compare treated embryos and
uninjected controls (Fig. 2I–L). Sixty somite sections were analysed
for each treatment from 24 hpf embryos. Analysis of the miR-30
morpholino treated embryos showed a significant increase in slow-
muscle fibre number and altered distribution to a more internal
position within the somite, suggesting an increase in Hedgehog
activity (Fig 2J and Table S1). The average slow muscle fibre
number in untreated embryo somites was 23.0163.13 (Fig. 2I),
compared to 38.0369.90 (p,0.0001) in miR-30 morpholino
treated embryos (Fig. 2J) and 17.566.4 (p,0.0001) in miR-30
overexpression embryos (Fig. 2L). The effect of miR-30 knock-
down was compared to the effect of Hh pathway overactivation by
injection of dnPKA mRNA [47]. DnPKA treated embryos showed
an extremely elevated slow fibre count with an average
55.4613.90 slow muscle fibres per somite (Fig. 2K).
miR-30 Acts to Negatively Regulate Smoothened
As with most microRNAs, many targets are predicted by
algorithms and sequence analysis [51]. Based on such analysis we
identified a potential miR-30 target site within the zebrafish
39UTR sequence of the transmembrane receptor smoothened (smo)
[52,53]. Smoothened is a key regulator of Hh pathway activity and
is responsible for transducing the signal produced by Shh to the
downstream pathway components. In the absence of Hh,
Smoothened activity is controlled by Ptc1 inhibition, which is
removed following binding of the Hedgehog ligand to the Ptc1
receptor [54]. In situ hybridisation analysis of smoothened shows an
overlap of expression with miR-30 family members, both
temporally and spatially throughout zebrafish embryonic devel-
opment, allowing for a potential interaction [44].
Figure 2. The miR-30 family is required during early embryonic development to regulate Hh pathway activity. Embryo somite
structure at 24 hpf is shown (A–D). Ptc1 expression analysis was used as a read out of Hh pathway activity, showing elevated levels in miR-30
morpholino and dnPKA treated embryos when compared to wild type embryos (E–H). Slow muscle fibre number was quantified by
immunohistochemistry using the S58 antibody (yellow/green) and MF20 staining (red). Embryo sections are orientated dorsal side upwards (I–L).
Images are shown of wild type embryos (A, E, I), miR-30 morpholino treated embryos (B, F, J), dnPKA treated embryos (C, G, K) and miR-30
overexpression embryos (D, H, L).
doi:10.1371/journal.pone.0065170.g002
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To test whether miR-30 directly targets the proposed target site
within the smoothened 39UTR, we assessed the ability of miR-30 to
negatively regulate three reporter mRNAs. Three different
constructs were generated, each containing the GFP ORF
followed by either tandem repeats of the miR-30 perfect target
site (GFP-PTS) (Fig. 3A–B), an entirely complementary sequence
to the microRNA, the smoothened 39UTR sequence (GFP-SMO)
(Fig. 3C–D), or no UTR sequence (GFP-no UTR) (Fig. 3E–F) as a
negative control. These mRNAs were injected into zebrafish
embryos either singly or in combination with the miR-30 duplex
sequence. GFP protein expression in embryos was verified using
Western Blot analysis on embryo lysates (Fig. 3G). Consistent with
a role for the miR-30 family in smoothened modulation a 54%
reduction was seen in the GFP-SMO+miR-30 embryos
(p = 0.0001) (Fig. 3D,G,H) when compared to embryos injected
with the GFP mRNAs alone, indicating an interaction between
smoothened 39UTR and miR-30. Significantly lower levels of GFP
were detected in the GFP-PTS+miR-30 embryos (p,0.0001)
(Fig. 3B) and GFP protein levels remained unchanged in embryos
injected with GFP- noUTR with or without miR-30 (p= 0.305)
(Fig. 3E–F). Further evidence of a direct relationship between
miR-30 and smo was shown by an increase of 73% in Smoothened
protein level following miR-30 morpholino treatment (Fig. 3I–J).
This increase was statistically significant with a p value of 0.0069.
To establish that Hh pathway activity is regulated by miR-30
via direct targeting of smoothened, rather than another pathway
component, ptc1 expression was compared in embryos overex-
pressing either Shh or dnPKA in conjunction with miR-30 (Fig. 4).
Sonic hedgehog mRNA was generated from the p64T expression
vector, previously described by Krauss et al., 1993 containing the
open reading frame of zebrafish Shh. The vector was linearised
with BamHI and mRNA transcribed with SP6 RNA polymerase,
capped and cleaned for microinjection into zebrafish embryos
[55]. As shown previously injection of dnPKA RNA leads to an
increase in ptc1 expression (Fig. 4D). Coinjection of dnPKA and
miR-30 RNAs also demonstrates elevated ptc1 levels (Fig. 4E).
Consistent with the location of Smoothened upstream of dnPKA
in the Hh pathway, overexpression of miR-30 is unable to suppress
the effect of dnPKA. However, the overexpression of a more
upstream pathway component such as Shh (Fig. 4F) is suppressed
by miR-30 overexpression (Fig. 4G) indicating the miR-30 target is
located between Shh and dnPKA in the pathway. The location of
the miR-30 target between these two components of the Hh
pathway adds further confidence to the hypothesis that smoothened is
the target gene.
To assess directly the effect of the miR-30-Smoothened
interaction on zebrafish muscle structure a smoothened target
protector morpholino was injected into embryos and the somite
structure analysed at 24 hpf. The protector is complementary to
the proposed target sequence within the smoothened 39UTR, and
specifically disrupts the miR-30-smoothened interaction [56,57], thus
providing valuable information about the physiological role of this
pair without the interference of other targets or potential
secondary targets [57]. These attributes have been demonstrated
in a number of studies of other microRNAs [58–61]. Figure 5
shows the somite structure of embryos injected with the target
protector. The resulting phenotype was milder than miR-30 family
knockdown, however a significant change in somite structure was
detected. Angle measurements were taken from wild-type, miR-30
morpholino and protector-injected fish (Fig. 5A–D). All analyses
were conducted blind. The mean somite angle in the protector-
injected fish (Fig. 5C) was significantly more obtuse than that of
the wild-type controls (Fig. 5A) (independent t-test: t = 6.3574,
df = 1005, p (one-tailed) ,0.0001). The mean angle for wild-type
fish was 94.37u (SEM=0.27), compared to 109.2u (SEM=2.84)
for miR-30 morpholino injected fish and 97.08u (SEM=0.34) for
those injected with the smoothened protector (Fig. 5D).
To confirm that the observed phenotypic, transcript and protein
alterations were directly due to miR-30 regulation of smoothened we
sought to rescue the miR-30 morpholino phenotype using the
Smoothened inhibitor cyclopamine (Fig. 5E–M and Fig. S4) [54].
Cyclopamine is a plant derived alkaloid which directly targets
Smoothened and consequently inhibits hedgehog signalling [54].
Embryos were injected with the miR-30 morpholino and allowed
to develop in water treated with cyclopamine, dissolved in DMSO,
at a range of concentrations between 100 mM and 6.25 mM. The
optimum cyclopamine concentration for rescue of the miR-30
morpholino phenotype was 6.25 mM, which achieved rescue of the
somite structure in 70% of embryos. To evaluate the phenotypic
rescue, embryos were monitored up to 24 hpf and the resulting
phenotype was assessed for improved overall morphology and
somite structure. Cyclopamine rescue yielded miR-30 morpholino
treated embryos with more obvious chevron-shaped somites
(Fig. 5K). Ventral curvature of the embryos was improved leading
to an overall extended morphology similar to that in wild-type
embryos (Fig. 5E).
Detailed analysis of the somite structure was carried out on the
four somites immediately posterior to the yolk cell extension at
24 hpf following cyclopamine rescue. Analysis of the somite
boundaries showed that miR-30 morpholino embryos treated with
cyclopamine had an improved angular somite structure (Fig. 5K)
that more closely resembled that of the wild type embryo somite
(Fig. 5E). In parallel both uninjected and miR-30 morpholino-
injected embryos were treated with identical amounts of DMSO to
act as a negative control which produced no effect on the
phenotypes of the resulting embryos (Fig S4C+D). Furthermore, a
reduction in ptc1 expression was observed following cyclopamine
rescue of miR-30 morpholino embryos indicating that Hh
pathway activity had been reduced (Fig. 5L). Immunohistochem-
ical analysis revealed that following cyclopamine treatment the
number of slow muscle fibres in miR-30 morpholino treated
embryos (38.0369.90) reduced to the wild type range
(23.0163.13) with an average of 24.163.58 slow muscle fibres
per somite (p = 0.0784) (Fig. 5G, 5J, 5M and Table S1). Together
our results indicate that cyclopamine inhibition of Smoothened
suppresses the phenotype associated with loss of miR-30 function,
supporting the hypothesis that miR-30 modulates Hh signalling by
regulation of smoothened.
Discussion
In the current study we have demonstrated that inhibition of the
miR-30 microRNA family causes elevated ptc1 expression and
increased numbers of superficial slow muscle fibres during
zebrafish muscle development, consistent with an increase in Hh
pathway activity. These features are a result of direct targeting of
the Hh transmembrane receptor smoothened by the microRNA
family, representing a novel role for miR-30 in muscle fibre
specification and distribution. This is supported by the observation
that miR-30 overexpression, and hence Hh pathway activity
reduction, can be rescued by coinjection with Shh mRNA but not
with dnPKA mRNA.
The inhibition of Smoothened is critical to controlled levels of
Hh activity within a cell, a function that is attributed to the
interaction of the Smoothened protein with Ptc [62]. It has been
shown that Ptc acts sub-stoichiometrically to suppress Smooth-
ened, demonstrating a catalytic mode of action rather than a direct
interaction between the two pathway components [63]. However,
miR-30 Targets smoothened in Zebrafish Muscle
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other work has shown that Ptc-mediated inhibition can be
overcome by high levels of Smoothened [64]. Here, we show that
such an increase in Smoothened protein levels is induced by
morpholino-mediated knock-down of the miR-30 family in
zebrafish embryos. This increase in Smoothened protein levels
leads to an up-regulation of Hh signalling in the developing
somites that ultimately results in a very specific muscle fibre
patterning defect, namely the development of slow instead of fast
muscle fibres. A similar defect had previously been described in
embryos in which the Hh pathway had been over-activated by
forced expression of Hh ligands or dominant negative PKA in all
tissues of the early embryo (35). The phenotype generated from
target protection of the miR-30 site within the smoothened mRNA
transcript, demonstrating the specific effect of this interaction,
produces a defect in early muscle specification resulting in
flattened somites and loss of the characteristic chevron structure.
The experiments conducted in this study demonstrate a critical
interaction between the miR-30 family and smoothened mRNA in
the developing zebrafish embryo. Increased Smoothened levels in
the somites results in an abnormal patterning of the muscle fibres.
In the miR-30 morphants, Smoothened levels are elevated and as
such the somitic cells located more laterally are capable of
pathway activation and hence develop into slow rather than fast
muscle fibres. In the wild-type embryo only adaxial cells receive a
Hh signal strong enough to relieve Ptc-mediated Smoothened
inhibition. Our data suggest that in the wild-type embryo miR-30
regulation of smoothened mRNA maintains the correct cellular level
Figure 3. miR-30 directly targets the 39UTR of the Hedgehog transmembrane receptor smoothened. (A–F) Embryos injected with 3
different GFP reporter mRNAs; (A,B) the GFP ORF plus tandem perfect target sites (GFP-PTS), (C,D) GFP ORF plus the smo 39UTR sequence (GFP-SMO)
and (E,F) the GFP ORF without UTR sequence (GFP- no UTR). Constructs were injected either alone (A,C,E) or with the miR-30 duplex RNA (B,D,F).
(G) Western blot validation on lysates of GFP injected embryos with and without the miR-30 duplex (H) Densitometric analysis of GFP protein levels
normalised against a-tubulin loading control shows a 54% reduction in GFP-SMO+miR-30 compared to GFP-SMO only embryos. (I) Protein blot
analysis of smoothened levels in wild type and miR-30 morpholino knockdown embryos shows an increased level of Smoothened protein. (J)
Densitometric analysis of the average change in smoothened protein level in 3 samples of wild type versus miR-30 morpholino treated embryos.
doi:10.1371/journal.pone.0065170.g003
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of Smoothened protein and the appropriate Ptc:Smo ratio to
ensure normal patterning of the somitic mesoderm.
Most microRNAs are fine tuning regulators, rather than early
developmental switches. In most situations this buffering effect
does not have major developmental consequences and micro-
RNAs function to maintain established expression profiles [42].
However, in particular contexts this negative regulatory function
has a critical role on key developmental processes [62].
MicroRNA-30 regulation of the Hh pathway, via modulation of
Smoothened, represents a prime example of a pathway that is
particularly sensitive to changes in its key components in some cell
types and therefore microRNA regulation represents an ideal
mechanism to maintain the level of control needed for precise
activation. By acting to modulate the activity of Smoothened, and
subsequently the entire Hh pathway, the miR-30 family undertake
a key role in early zebrafish embryonic development.
Materials and Methods
In situ Hybridization
Detection of mature microRNAs by in situ hybridization was
performed as previously described [39] using digoxigenin (DIG)-
labelled Locked Nucleic Acid (LNA) probes (Exiqon). Negative
control in situ hybridisation experiments used a sense LNA probe
designed against miR-159. Ptc1 in situ hybridisation was
conducted following standard techniques. Embryos were pooled
and treated for the same hybridisation and staining times.
Microinjections
Fertilized one-cell zebrafish embryos were injected with 6 ng
miR-30 morpholino in 1 nl (TGCATTATTACTCACGGTAC-
GAGTTTGAGTC), 50 pg of miR-30 duplex RNA and 50 pg
in vitro-transcribed capped GFP mRNAs. Zebrafish smoothened
39UTR sequence was amplified by RT-PCR and subcloned
downstream of the GFP ORF that was inserted into vector pCS2+.
A morpholino designed against smoothened was used to determine
antibody specificity, (GAGGACATCTTGGAGACGCAACAAA)
and injected at 2.5 ng per embryo (Fig. S3). The smoothened
target protector sequence was GTGTATGTAAACACCA-
TAAACTGAC and was injected at 9 ng/embryo.
Immunohistochemistry
Embryos were immersed in 30% sucrose for 60 minutes and
frozen in OCT (R A Lamb) using liquid nitrogen cooled
isopentane. 20 mm-thick sections were cut on a cryostat (Microm
HM505E) and collected on APES COATED glass slides. Frozen
sections were fixed in 1% PFA and blocked in 5% BSA:PBS with
triton-X to a final concentration of 0.3%. Antibodies were mouse
monoclonal against myosin heavy chain (S58) 1:50 dilution, and
myosin (MF20) 1:100 dilution. Monoclonal antibodies, S58
developed by F.E. Stockdale and MF20 developed by D.A
Fischman, were obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD
and maintained by The University of Iowa, Department of
Biology, Iowa City, IA 52242. Secondary antibodies against mouse
IgG were Alexafluor labeled 488 (green fluorescent) and 555 (red
fluorescent) and used at 1:300 dilution (Invitrogen). Sections were
mounted with Vectashield Mounting Medium with DAPI
(Vector).
Protein Blotting
Blots were probed with antibodies against GFP (Santa Cruz, sc-
9996) 1:200 dilution, a-tubulin (Santa Cruz, sc-5286) 1:400
dilution, and smoothened (Abcam, ab38686) 1:1000 dilution.
Secondary antibodies were conjugated to HRP and visualized with
ECL. Densitometric analysis of protein blots were done using
Molecular Dynamics ImageQuant 5.2 software. A commercially
available antibody against zebrafish smoothened has not yet been
described. However, an antibody raised against part of the human
protein, which shares 52% identity with the zebrafish sequence,
was predicted to interact with zebrafish smoothened. The
specificity of this antibody was tested on a Western blot containing
protein from zebrafish in which smoothened levels had been
knocked down by morpholino treatment (Fig. S3).
Cyclopamine Treatment of Zebrafish Embryos
Cyclopamine powder (Toronto Research Chemicals) was
dissolved in DMSO. Uninjected and morpholino injected embryos
were pooled in group sizes of 30 and exposed to cyclopamine, at 2
hours post fertilisation, at different concentrations diluted in 5 ml
of fish water. Cyclopamine concentrations ranged from 100 mM-
2.5mM. Control uninjected and injected embryos were treated
with identical amounts of DMSO diluted in fish water. Embryos
were incubated at 28uC and analysed at 24 hpf.
Imaging
Brightfield and in situ hybridization embryos were imaged using
a Zeiss Lumar V.12 microscope and MTI DC-330 video capture
digital camera. Immunohistochemistry treated embryos were
imaged using a Zeiss 5.10 confocal microscope. Images were
acquired using Improvision Openlab and LSM image software.
Statistical Analysis
An independent t-test, one-tailed, was used to determine the
significance in the somite angle measurements. We performed a
two-tailed t-test to determine statistical significance between the
number of slow muscle fibres in the different somite sections.
Differences were established at a 99% confidence interval.
Figure 4. Analysis of Ptc1 reveals the position of miR-30
regulation in the Hh pathway. Ptc1 in situ hybridization shows the
level of Hh pathway activity in different embryo treatment types. (A)
Wild type embryo, (B) miR-30 overexpression embryo, (C) miR-30
morpholino injected embryo, (D) dnPKA overexpression embryo (E)
dnPKA RNA injected with miR-30 duplex (F) Shh overexpression embryo
(G) Reduced ptc1 expression is seen in Shh overexpression embryos
coinjected with miR-30 RNA as miR-30 is able to suppress pathway
activity.
doi:10.1371/journal.pone.0065170.g004
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Supporting Information
Figure S1 (A) Expression of the miR-30 family as determined by
in situ hybridisation at 8, 16 and 26 hpf. Embryos are orientated
anterior to the left and dorsal up. Expression is ubiquitous with
predominant expression in the cerebellum, retina and somites, as
indicated (arrows). miR-30e shows additional expression in the
linear heart tube (arrowhead) (B) Negative control in situ
hybridisation using a sense miR-159 LNA probe shows no
detectable expression at 8 hpf, 16 hpf and 24 hpf. (C) Negative
control morpholino against miR-140 showed no detectable
phenotype when injected at the same concentration as the miR-
30 morpholino upto 3 dpf.
(TIF)
Figure S2 Validation of the miR-30 morpholino. (A)
Injection of zebrafish embryos with GFP fused to a 39UTR
containing (1) tandem miR-30 perfect target sites (GFP-PTS). (2)
Co-injection of miR-30 RNA with the GFP-PTS reporter mRNA.
(3) Co-injection of miR-30 RNA and the miR-30 morpholino with
the GFP-PTS reporter. (B) Western blot of embryos as in 1–3 with
antibodies against GFP and a-tubulin as a loading control. (C)
Histogram to quantify the restoration of GFP protein following
miR-30 morpholino coinjection. GFP levels are normalised
against a-tubulin and presented as a percentage of the GFP-PTS
injected embryos.
(TIF)
Figure S3 Specificity of the human smoothened anti-
body to the zebrafish smoothened protein. Specificity of
the antibody was tested by Western blot on embryos injected with
the miR-wild type embryos and embryos injected with a
smoothened morpholino. The substantially reduced band at
32 kDa in the smoothened morpholino treated embryos shows
cross reactivity of the human antibody with the zebrafish protein
and allowed for quantification of smoothened protein levels.
(TIF)
Figure 5. miR-30 acts to negatively regulate smoothened in developing embryos. (A–D) Somite angle analysis in wild type, miR-30
morpholino and smoothened protector morpholino injected embryos. Somite structure of (A) wild type embryos (B) miR-30 morpholino injected
embryos (C) smoothened protector morpholino injected embryos. (D) Histogram to show the average somite angle in wild type and treated
embryos. (E–M) Cyclopamine treatment causes reversion in somite structure to a more wild type phenotype. Images as shown of wild type embryos
(E,F,G), miR-30 morpholino embryos (H,I,J) and miR-30 morpholino embryos treated with cyclopamine (K,L,M). The somite structure of (E) wild type
(H) miR-30 morpholino and (K) miR-30 morpholino and cyclopamine treated embryos. (F, I, L) Expression of ptc1 is substantially reduced following
cyclopamine treatment (L). Embryos are shown with anterior end to the left and dorsal side up. (G,J,M) The expanded band of slow fibres, as stained
by S58 antibody, is restored to the wild type distribution following cyclopamine treatment (M). Embryo sections are orientated dorsal side to the left.
doi:10.1371/journal.pone.0065170.g005
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Figure S4 Cyclopamine treatment rescues the miR-30
morpholino phenotype. To achieve phenotypic rescue of the
miR-30 morpholino phenotype cyclopamine was used at a
concentration range of 100 mM-6.25 mM. At 6.25 mM the miR-
30 morpholino phenotype improved to resemble the wild type
phenotype with elongation of the tail and improved somite
structure (F). Cyclopamine was dissolved in DMSO and both wild
type and miR-30 morpholino injected embryos were treated with
DMSO as a negative control (A–D) which had no effect on
embryo development when compared to untreated. Wild type
embryos treated with 6.25 mM cyclopamine showed a mild
phenotype associated with Hh pathway inactivation with U
shaped somites and a loss of brain chamber definition (E).
(TIF)
Table S1 Number of muscle cell types in miR-30
morpholino treated embryos. Slow muscle fibres were
visualised by fluorescent immunohistochemistry as in figures 2
and 5. Values are the mean slow muscle fibre number per somite.
The number of somites analysed of each embryo type is 60. We
performed a two-tailed t-test to establish significance within a 99%
confidence interval.
(TIF)
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